Therapeutic Decision-Making in the Adjuvant Setting in HR+ Breast Cancer - Episode 9
May 27, 2021
Implications for using the Oncotype DX Breast Recurrence Score to help tailor therapy for patients with HR-positive, HER2-negative breast cancer based on data demonstrated in the TAILORx and RxPONDER studies.
"breast" - Google News
May 27, 2021 at 08:25PM
https://ift.tt/3vqSemg
The Oncotype DX Breast Recurrence Score for HR+ Breast Cancer - Cancer Network
"breast" - Google News
https://ift.tt/2ImtPYC
https://ift.tt/2Wle22m
Bagikan Berita Ini
0 Response to "The Oncotype DX Breast Recurrence Score for HR+ Breast Cancer - Cancer Network"
Post a Comment